2-(5-Methyl-1,2,4-oxadiazol-3-yl)propan-2-amine hydrochloride → HCID 71525944, 화합물
반응식
[CH:1]1([C:4]2[N:5]=[CH:6][C:7]([C:15]([OH:17])=O)=[N:8][C:9]=2[O:10][CH2:11][CH:12]2[CH2:14][CH2:13]2)[CH2:3][CH2:2]1.Cl.[CH3:19][C:20]([CH3:28])([C:22]1[N:26]=[C:25]([CH3:27])[O:24][N:23]=1)[NH2:21]>>[CH3:19][C:20]([NH:21][C:15]([C:7]1[CH:6]=[N:5][C:4]([CH:1]2[CH2:2][CH2:3]2)=[C:9]([O:10][CH2:11][CH:12]2[CH2:13][CH2:14]2)[N:8]=1)=[O:17])([C:22]1[N:26]=[C:25]([CH3:27])[O:24][N:23]=1)[CH3:28]참가 물질
3
실험 절차
The title compound was synthesized in analogy to Example 6, using 5-cyclopropyl-6-cyclopropylmethoxy-pyrazine-2-carboxylic acid (Example 10 g) and α,α,5-trimethyl-1,2,4-oxadiazole-3-methanamine hydrochloride (CAN 1240526-27-5) as starting materials, and isolated (64 mg, 84%) as light yellow solid; LC-MS (UV peak area, ESI) 100%, 358.1869 (M+H).
후처리
- customisolated (64 mg, 84%) as light yellow solid